The Bayer Group has reported significant gains in sales, earnings and cash flow for 2005. Sales rose by 17.6% year-on-year to €27.383 million compared with €23.278 million in 2004.

The expansion in sales was attributed in part to the consumer health products acquired from Roche and to business with Lanxess.

Share this story: